Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respiratory Failure In Children
PHASE2CompletedINTERVENTIONAL
Enrollment
48
Participants
Timeline
Start Date
January 1, 2016
Primary Completion Date
February 6, 2019
Study Completion Date
June 20, 2020
Conditions
Respiratory Syncytial Virus
Interventions
DRUG
Azithromycin 10 mg
DRUG
Azithromycin 20mg
DRUG
Placebo
Trial Locations (1)
35233
UAB, Birmingham
All Listed Sponsors
lead
University of Alabama at Birmingham
OTHER
NCT02707523 - Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respiratory Failure In Children | Biotech Hunter | Biotech Hunter